Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-022324
Filing Date
2018-08-14
Accepted
2018-08-14 17:30:40
Documents
2
Period of Report
2018-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7400
2 EX-24 DOCUMENT attachment1.htm EX-24 3061
  Complete submission text file 0000899243-18-022324.txt   11990
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BUCKHEAD PLAZA, SUITE 400 3060 PEACHTREE ROAD NW ATLANTA 2Q 30305
Business Address
Klump Michael A (Reporting) CIK: 0001748882 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-49908 | Film No.: 181019042